Posted on

חדשות ביראד – אפריל 2018

חוקר/ת יקר/ת,

“עלון חוקרים” חודש אפריל מרכז עבורכם את ה”קולות קוראים” החדשים עם הרשות לחדשנות ועם התעשייה.

נודה באם תקדישו מזמנכם לפתוח אותו ולקרוא את התכנים אשר בו, על מנת לבדוק היתכנות לשת”פ. צוות ביראד עומד לרשותכם בכל שאלה או בקשה.

בהזדמנות זו, חוקרים יקרים, לקראת יום העצמאות למדינת ישראל, אנו יכולים להסתכל בגאווה על ההישגים המחקריים/ האקדמיים שלכם שהצמיחו פיתוחים טכנולוגיים מתקדמים לטובת אוכלוסיית העולם.

מי ייתן ושנת העצמאות השבעים של מדינת ישראל הבאה עלינו לטובה, תהיה שנה של שלום ואחווה, שנה של כבוד הדדי ושוויון, שנה של סובלנות והקשבה, שנה של צמיחה ושגשוג!

חג עצמאות שמח,

ד”ר צביקה בן-פורת

מנכ”ל ביראד

 

Posted on

CogniFiber has been selected to take part in Intel’s Ingenuity Partner Program (Intel IPP)

As part of the program, CogniFiber will be mentored by experts from Intel’s business organizations, will be exposed to state-of-the-art technology, along with an educational infrastructure and local and international events.

CogniFiber has been chosen to participate in the fourth cycle of Intel’s prestigious program for leveraging startups. The program’s framework is based on a demo and POC which is built on defining joint project goals for CogniFiber and Intel. The company will gain mentoring by experts from Intel’s business organizations, will be exposed to state-of-the-art technology, together with an educational infrastructure and local and international events.

Cognifiber is a leader in the field of photonic computing, the emerging technology of the next decades. The primary development of the technology on which the company was founded was done by Dr. Eyal Cohen, who performed a post-doctorate research in the laboratory of Prof. Zeev Zalevsky, from the Faculty of Engineering, in Bar-Ilan university in collaboration with Dr. Mickey London from The Interdisciplinary Center for Neural Computation (ICNC), The Hebrew University of Jerusalem, as an additional advisor. Dr. Eyal Cohen approached the two with a proposal to carry out the research and with Prof. Zalevsky’s extensive experience, promoted the research and its commercialization through BIRAD, Research & Development company Ltd. and the Deputy President of Bar-Ilan university.

Dr. Eyal Cohen together with Prof. Zalevsky and Ms. Keren Levy, who served as a business advisor for the company, co-founded the company. Dr. Eyal Cohen, acts as the leading entrepreneur and company CEO, Prof. Zeev Zalevsky is the company CTO and Keren Levy acts as the company COO.

CogniFiber implements advanced algorithms such as machine learning and deep learning neural networks within unique optic fibers, which enable up to 10,000x acceleration in computation rate, coupled with a staggering 10x-100x reduction in power consumption and heat dissipation, at these computation rates. CogniFiber’s photonic devices will not only revolutionize the world of AI and computing, but will also make AI cheaper, more mobile and more accessible. In-fiber photonic computing devices can deliver a solution for the ever-growing processing needs, they are easy to manufacture, scalable, fault-resistant, and could be connected to any existing communication platform.

Intel’s IPP program is open (every cycle) for about 10 companies and offers them 6-8-months of professional mentoring framework to improve their technology and products, while leveraging on Intel’s technological resources, global presence, and vast network of business connections, in preparation for a successful market penetration. The program is in collaboration with Intel Capital, one of the world’s biggest Venture Capitals, which enables entrepreneurs direct access to this track.

The IPP program, which began operating in 2015, has accompanied about 30 companies, which raised a total of 281 million dollars between them in the past three years. 93% of the companies are still active, and Intel does not demand or take equity or percentages.

With the purchase of Mobileye, Replay, and positioning Intel as a data company, Intel is without a doubt a central player in all emerging and exciting technologies of today’s industry and acts as an excellent source for entrepreneurs who want to accelerate their product or technology.

http://www.Intel.com/ipp

BIRAD:

Birad – Research & Development Company Ltd. the commercializing company of Bar-Ilan University, which promotes innovative technology commercialization, invented by university researchers, encourages scientists to promote their researches and expand them towards industrial and implementational initiatives.

Additional details at the company’s site: www.birad.biz

For additional info regarding CogniFiber: http://www.cognifiber.com

For additional details: Merav Burstein – 052-2229330 – merav@birad.biz

 

 

Posted on

Researchers Invent Nano-Drops That Improve Nearsightedness and Farsightedness

 

Nano-Drops May Offer New Alternative to Current Methods of Vision Correction

Ramat Gan, Israel — A revolutionary, cutting-edge technology, developed by researchers at Bar-Ilan University’s Institute of Nanotechnology and Advanced Materials (BINA), has the potential to provide a new alternative to eyeglasses, contact lenses, and laser correction for refractive errors.

The technology, known as Nano-Drops, was developed by Dr. David Smadja (Ophthalmologist from Shaare Zedek Medical Center), Prof. Zeev Zalevsky, from Bar-Ilan’s Kofkin Faculty of Engineering, and Prof. Jean-Paul Moshe Lellouche, Head of the Department of Chemistry at Bar-Ilan. A related patent on this new invention was recently filed by Birad – Research & Development Company Ltd., the commercializing company of Bar-Ilan University.  Steve Elbaz is a Co-Founder and Chief Business Officer of the new technology.
Nano-Drops achieve their optical effect and correction by locally modifying the corneal refractive index. The magnitude and nature of the optical correction is adjusted by an optical pattern that is stamped onto the superficial layer of the corneal epithelium with a laser source. The shape of the optical pattern can be adjusted for correction of myopia (nearsightedness), hyperopia (farsightedness) or presbyopia (loss of accommodation ability). The laser stamping onto the cornea takes a few milliseconds and enables the nanoparticles to enhance and ‘activate’ this optical pattern by locally changing the refractive index and ultimately modifying the trajectory of light passing through the cornea.

The laser stamping source does not relate to the commonly known ‘laser treatment for visual correction’ that ablates corneal tissue. It is rather a small laser device that can connect to a smartphone and stamp the optical pattern onto the corneal epithelium by placing numerous adjacent pulses in a very speedy and painless fashion.  Tiny corneal spots created by the laser allow synthetic and biocompatible nanoparticles to enter and locally modify the optical power of the eye at the desired correction.

In the future this technology may enable patients to have their vision corrected in the comfort of their own home. To accomplish this, they would open an application on their smartphone to measure their vision, connect the laser source device for stamping the optical pattern at the desired correction, and then apply the Nano-Drops to activate the pattern and provide the desired correction.

Upcoming in-vivo experiments in rabbits will allow the researchers to determine how long the effect of the Nano-Drops will last after the initial application. Meanwhile, this promising technology has been shown, through ex-vivo experiments, to efficiently correct nearly 3 diopters of both myopia and presbyopia in pig eyes.

Posted on

חדשות ביראד – מרץ 2018

חוקר/ת יקר/ה

צוות החוקרים של אוניברסיטת בר-אילן מהווה קבוצה איכותית וערכית בתרומתה לקידום האנושות, בתחומים רבים ומגוונים, החל מביולוגיה ימית, דרך דימות, אופטיקה, מחשוב, תקשורת ואבטחת מידע, מחזור אנרגיה וביופיזיקה, ועד חקר הסרטן, מחלות זקנה, מחשוב ומדעים קוגניטיביים.

מחקרים רבים הנולדים בתוך מעבדות האוניברסיטה מתפתחים לידי מחקרים יישומים בעלי פוטנציאל מסחרי.

תפקידנו הוא לעודד אתכם לקדם את מחקרכם לתחומי המחקר היישומי, ולכן בעלון זה תמצאו רשימת פרויקטים ומיזמים מעניינים לשיתופי פעולה עם האקדמיה. כמו גם דוגמאות של סיפורי הצלחה חדשים של עמיתכם החוקרים.

אני מקווה כי העלונים החודשיים, אתר האינטרנט החדש וצוות ביראד המיומן יסייעו לכם וידרבנו אתכם להגיש בקשות לפרויקטים.

בהצלחה לכולנו!

ד”ר צביקה בן-פורת

מנכ”ל ביראד

Posted on

ContinUse Biometrics one of ten start-ups to take first place in 2018 Prism Awards for breakthrough applications in photonics

Company recognized for its development by Bar-Ilan University engineering professor of a biometric sensing system that detects biomedical parameters from a distance without human contact

Israeli start-up ContinUse Biometrics is among the ten first-place winners of the prestigious 2018 Prism Award (the Oscar of the photonics industry) for the Medical and Health category.  The company is being recognized for its invention of an optical sensing system (sensory camera) in a competition sponsored by Photonics and SPIE Media This is the tenth year that the competition has been held.

“We chose the ten companies that introduced the greatest innovation and creativity in their products and showed impressive data and performance in every possible parameter.  These are inventions that, without a doubt, advance the photonics industry and its prosperity,” noted the organizers of the competition.

ContinUse Biometrics took first place for its laser-based detector and camera that remotely and accurately identify nanoscale movements.  The sensor is aimed at the subject, enabling accurate physiological data to be obtained.

ContinUse Biometrics focuses on developing novel devices for the health field in general and preventive medicine in particular — for use in the home, the vehicle, the workplace and the clinic.  Its products enable ongoing monitoring of vital indicators and patients suffering from chronic diseases such as heart disease, respiratory diseases, and more.

The products developed by ContinUse Biometrics is ideal for senior citizens by virtue of the fact that it transfers medical care from the doctor’s office to the home environment and alerts medical professionals to any change in vital indicators.  The attending physician receives all the readings remotely and provides appropriate medical instructions to the patient. This Telemedicine platform has the potential to minimize visits to clinics and/or hospitalization, while monitoring the patient in his own home in a comfortable, non-contact environment and increased level of service.

The detector is based on the development of Bar-Ilan University engineering professor Zeev Zalevsky, Chief Technology Officer of ContinUse Biometrics. . The detector identifies several groups of physiological parameters including vital signs such as heartbeat,, breathing and blood pressure; allows for listening to heart and breathing sounds (much like a stethoscope); identifies changes in peripheral blood flow patterns; identifies hematologic parameters; identifies people according to their heart tone; and provides muscle and bone measurements including changes in muscle tone and detection of fractures. All measurements are conducted remotely, with no human contact.

The response of medical markets to this development has been most enthusiastic, and the business potential is estimated at hundreds of millions of dollars. In addition, the company plans to activate the sensor in clinics and operating rooms. In this framework, the company will perform several hospital clinical trials over the coming year.

ContinUse Biometrics was founded by CEO Asher Polani with assistance from Bar-Ilan University’s BIRAD Research and Development Company Ltd., which promotes the commercialization of innovative technologies invented by university researchers, and encourages scientists to advance and expand their research with an eye toward industrial applications.

For further information, contact: Merav Burstein, BIRAD Research and Development Company Ltd., 077-3643534, 052-2229330, Merav@birad.biz

 

 

Posted on

A physicist from Bar Ilan’s Institute for Nanotechnology and Advanced Materials and her colleagues in the QUANTOX project are developing a Quantum computer funded by the prestigious QuantERA Fund

Dr. Beena Kalisky, from the Department of Physics and Bar Ilan’s Institute for Nanotechnology and Advanced Materials, together with researchers from France, Italy, the Netherlands, Spain and Sweden, are developing Quantum Technology using 2D interfaces created between oxides as part of the QUANTOX project (QUANtum Technologies with 2D-Oxides).

The research is budgeted by QuantERA, a European Research Fund, that brings together 31 research funding agencies from 26 countries, coordinated by the National Science Centre in Poland, and the Israel Innovation Authority (formerly known as “The Chief Scientist”).

Developing a quantum computer is one of the most desirable objectives today, and researches in the field are supported by powerful organizations such as Microsoft, Bell Labs, IBM and Google. Quantum computation will have a major effect on the computer’s performance and information security. Developing such a computer first requires the development of a basic memory cell, Qubit, using technology which is topologically protected. Despite the immense technological challenge, the advantage of such computers in speedy calculations and noise resistance, lead the significant investment in research and development of the field.

The proposed approach of the research team of QUANTOX is to use the diverse characteristics of Oxide interfaces to develop Quantum Topological systems that can be easily integrated within the current technology. These interfaces possess a unique combination of physical qualities that according to theoretical forecasts, will enable the implementation of the necessary conditions for developing a basic memory cell.

The development process is both challenging and complex. In this project the challenge is especially significant due to the technological difficulty of measuring phenomena based on minute electrical currents in substances with a 2D flow. The lab headed by Dr. Kalisky, develops highly sensitive sensors for measuring magnetic fields, and use it to map tiny magnetic fields that are generated by a small number of electrons, or very weak electrical currents. The measurement is conducted in Dr. Kalisky’s lab, in a local and non-invasive fashion, allowing feedback for the development process, even before reaching the complex stages of connecting a memory cell to the entire system, and so enabling the development to be focused and accelerated.
Beena: “The highly sensitive magnetic imaging tool which we operate in the lab is very helpful for development stages.. Especially in fields of research conducted at cold temperatures. Exciting quantum physics takes place at temperatures close to the absolute 0 and we are excited to harness our research tools to these major objectives.”

The agreement between the parties was carried out by Birad – Research & Development Company Ltd. the commercializing company of Bar-Ilan University, which promotes collaborations, corporations and alliances to manage the intellectual property, and technology commercialization by creating risk and licensing, promoting scientific service agreements through the technological knowledge and infrastructure of the University for the benefit of members of the industrial community, and outsourcing services for the business sector as part of the Division of Scientific Services.
For additional info: Merav Burstein – 052-2229330 – merav@birad.biz

Posted on

חדשות ביראד – פברואר 2018

חוקר/ת יקר/ה,
אני מתכבד להגיש לכם את גיליון פברואר 2018, ט״ו שבט תשע״ח, בו מפורטים הפרויקטים החדשים לשיתופי פעולה עם התעשייה והרשות לחדשנות. פרויקטים אלו הינם בבחינת הזדמנות נפלאה לכולנו לקחת חלק בפיתוח מוצרים, שירותים והידע של המחר.
החיבורים בין אנשי אקדמיה לבין אנשי תעשיה יוצרים חדשנות. מדינת ישראל רואה בחדשנות משאב יקר ערך, ופועלת לחיזוק החדשנות הישראלית תוך ביסוסה כנכס לאומי משמעותי בשגשוג המשק הישראלי.
קצב החיים של ימינו, ההתקדמות הטכנולוגית והתחרות העצומה בכל תחום ותחום לא מאפשרים לנו לשבת בחיבוק ידיים ולא להיות חלק מהתהליכי החדשנות מסביבנו. חדשנות היא משאב הטבע שלנו!.
אתם החוקרים מהווים נדבך חשוב וקריטי במיזמי החדשנות בהווה ושל המחר, בתחומים רבים ומגוונים. כדוגמת, פיתוח תרופות מצילות אדם, חקר הסרטן, בינה מלאכותית, גידולים וזנים איכותיים ועוד.
גיליון זה יוצא בט”ו בשבט. ט”ו בשבט נבחר לציין את הגבול בין הפריחה של השנה שעברה ובין הפריחה של השנה הבאה. הוא גם ראש השנה לאילנות שמסמל עבורנו הזדמנות להתפתחות חדשה. אני מאמין כי הזרעים שנשתול היום יצמיחו את הפירות של המחר.
ואסיים בברכה בסימן ט”ו בשבט. והייתם “כעץ שתול על פלגי מים, אשר פריו ייתן בעתו ועלהו לא יבול וכל אשר יעשה יצליח” (תהילים א’, ג’).
שלכם,
ד”ר צביקה בן-פורת
מנכ”ל ביראד

 לחדשות-ביראד-מרץ-2018

Posted on

The Management and Organizational “Postponement” Sickness

“Do not put off to tomorrow what you can do the day after tomorrow”; “We will cross that bridge when we get to it”; “Go to the ant, you sluggard; consider its ways and rest in the shade”; “We will handle it immediately after New Year” – these sayings and many others characterize an entire behavioural culture. Leaving things to the last minute has no value. A seminar paper written one day before it is due is unlikely to be worth mentioning in the academy’s yearbook as the best seminar paper of the year. A negotiation held with teachers a few hours before the end of the school year cannot exactly be considered fair. Unfortunately, in many cases, possibly too many, that is how things are done. And we are not discussing a local phenomenon, but something that happens almost everywhere around the globe.

The “don’t worry, be happy” virus, the “trust me” germ and the “there are more important things now” bacteria can cause a whole country to suffer from one serious illness – postponement sickness. Instead of doing what is needed at the right time and place and in the right amount, we often do things according to timetables that do not necessarily fit the commitments we have taken upon ourselves or were assigned to us. Sometimes we will first do things that are more urgent but not necessarily more important, and sometimes we will act according to the principle of ‘he who yells loudest’ and not according to ’the first thing that should be done’. In most cases we do not have bad intentions, but the result can be very destructive.

Even in the field of decision making there are many good people who suffer from the malignant disease of inability to reach a decision. Why make the decision now, they ask in wonder, when we can discuss this again in two or three weeks. Whoever had the pleasure of working with government authorities can testify that postponement is one of the cornerstones of their activities. It always seems that any decision (not to mention action) made by a government authority, local authority, government office, public corporation etc. requires a huge allocation of resources to move even the smallest of things.

The postponement sickness in execution and decision making does not afflict only the public sector but exists even in some of the businesses and organizations in the private sector. Only too often things are put off not only to the last minute, but even to the moment after that. The preparations towards a professional exhibition, the opening date of which was known six months earlier, ends a good couple of hours after the arrival of the first visitors and that is also when the flyers and handouts arrive. Postponement sometimes becomes standard procedure. Salary negotiations with teachers are almost always postponed to the last day of summer vacation. Marathon discussions with employees regarding salary increase are held moments before a general strike is declared. Where were these people earlier? Why didn’t they act before the last minute?

Postponement carries a heavy price of mediocrity. You cannot write a serious seminar paper, a process which should take about four months, within 11 hours. You just can’t. Just as you can’t speed up cooking or the tree-growing processes, you cannot speed-up processes that by nature require time. Proper preparation for an exam in engineering is not possible one day before the test. Only a few hours of studying for the SATs are not the same as taking a three or four month class. We will pay the price of mediocrity not only when the grade or the quantitative results arrive, but also in ‘qualitative’ parameters – which are harder to measure but easier to feel. It is called ‘whatever’ and can be seen on people, businesses or organizations that haven’t looked at the calendar recently or haven’t properly read the instructions of the tasks they took upon themselves or were assigned to them. Mediocrity is a result of postponement.

The business world is also afflicted with postponement. Starting with the preparations towards submitting reports or writing an official opinion, through discussions held minutes before making a decision and up to executives arriving at a meeting unprepared and reading materials sent to them in advance at the last minute. Only too often the business world finds itself in situations in which decisions or performances are postponed for no practical reason.

What can we do about postponement? High self-discipline is the basis of facing the tendency to postpone, ours and the people we work with and depend on. Self-discipline is based on an inner need not to cut corners (even when we can), on very high motivation and on the aspiration to achieve and to succeed. But no less important – it is based on the ability to perform actions even if we won’t get applauded for them or alternatively even if no one will punish us if we do them wrong.

Self-discipline has a huge significance when trying to deal with postponement sickness. Why do people arrive at the dentist’s for root canal or filling a cavity only when the pain becomes unbearable? Why don’t they go once every six months or even once a year for the routine check-up as required? The answer, again, is – self-discipline. There is no (immediate) punishment for not going to the dentist’s. On the other hand, the reward is immediate. You can always find something more pleasant and less painful to do. Even the reward for emptying your car ashtray on the road (late at night, when nobody is looking) is much more immediate than the punishment of living in a dirty country in the long run.

Unfortunately, too many factors award postponement with undeserved legitimacy. Instead of condemning postponement and turning it into a bad word, some systems just make it a way of life. The war against postponement should be held in the country institutions, in the local governance or school managements, in boards of directors and by each and every citizen. Self-discipline and willingness to work according to importance and not necessarily according to urgency will lead the social and business activities to other, much better, places. Early planning and management according to goals will also help getting rid of momentary whims that cause some people to prefer the easier present rather than hard work that ensures a better future.

Posted on

הרשם לגיליון החדשות לחוקרים של חברת ביראד

הרשם עוד היום לגיליון החדשות לחוקרים של חברת ביראד .

ביראד היא חברה בבעלות מלאה של אוניברסיטת בר-אילן האחראית על מסחור הטכנולוגיות החדשניות, אותן ממציאים חוקרי האוניברסיטה. החברה מעודדת מדענים לקדם את מחקריהם ולהרחיב אותם בכיוון של מיזמים יישומיים ותעשייתיים.

לפרטים נוספים ולרישום :

לחץ על – Read More

להרשמה : לחץ כאן

Posted on

גיליון החדשות הראשון לחוקרים של חברת ביראד – ינואר 2018

חוקר/ת יקר/ה,
אני מתכבד להגיש לכם את גיליון החדשות הראשון לחוקרים של חברת ביראד – חברה למחקר ופיתוח בע”מ של אוניברסיטת בר-אילן.
ביראד היא חברה בבעלות מלאה של אוניברסיטת בר-אילן האחראית על מסחור הטכנולוגיות החדשניות, אותן ממציאים חוקרי האוניברסיטה. החברה מעודדת מדענים לקדם את מחקריהם ולהרחיב אותם בכיוון של מיזמים יישומיים ותעשייתיים.
עם כניסתי לתפקיד לפני למעלה מחצי שנה, שמתי את נושא השירות והקשר עם החוקרים בראש סדר העדיפויות של החברה. בתקופה זו ביצעתי מספר מהלכים ארגוניים על מנת לתת לכם חווית שירות טובה ומקצועית, הכוללת: מתן מענה מקצועי ומהיר על ידי צוות העובדים, ניצול מירבי של מגוון מקורות המימון שעומדים לרשות החוקרים (מגנט, מגנטון, קמין, נופר וכדומה) ותשואה מקסימלית בכל תהליך מסחור וכיוצ“ב.
בעלון זה ובבאים אחריו, שישלחו פעם בחודש (מבטיחים שלא להציק)  אנו נרכז עבורכם את כל הפרויקטים החדשים (”קול קורא“) בכל התחומים, שבהם אנו חושבים כי לחוקרי האוניברסיטה יש את הידע והטכנולוגיות לקחת בהם חלק, ונשתף אתכם במידע חדשותי, עדכונים והחלטות בתחום המסחור הקניין הרוחני, תקציבי פיתוח ומענקים שאושרו לקידום המחקר היישומי, שת”פ עם חברות תעשיה, סיפורי הצלחה עוד.
אני מאמין כי הפעילות והעשייה המשותפת בין האוניברסיטה לביראד תעמיק את הקשר והמחויבות ההדדית בין חוקרי האוניברסיטה, הקהילה המדעית וגורמים בתעשייה, למען כלכלת ישראל ולרווחת תושביה.
אין לי ספק כי על בסיס שותפות מצוינת זו נמשיך לפעול יחדיו לביצוע משימות והיעדים שהצבנו לעצמנו.
שלכם,
ד”ר צביקה בן-פורת
מנכ”ל ביראד